| SCHEDULE OF DEBT |
The
following table presents the details of the principal outstanding:
SCHEDULE
OF DEBT
| | |
December 31, 2025 | | |
December 31, 2024 | | |
APR on December 31, 2025 | | |
Maturity | | |
Collateral |
Convertible Notes (b,c,) | |
$ | 18,834,348 | | |
$ | 15,592,408 | | |
| 0.00 – 10.00% | | |
| September 2023-
October 2030
| | |
Substantially all Company assets |
Notes payable to financial institutions and others (a) | |
| 501,495 | | |
| 4,515,297 | | |
| 3.75-8.5% | | |
| August 2025- November 2052 | | |
Substantially all Company assets |
| | |
| | | |
| | | |
| | | |
| | | |
|
| Total | |
$ | 19,335,843 | | |
$ | 20,107,705 | | |
| | | |
| | | |
|
| Unamortized debt discount | |
| (2,363,231 | ) | |
| (3,477,227 | ) | |
| | | |
| | | |
|
| Debt, net of Unamortized debt Discount | |
$ | 16,972,612 | | |
$ | 16,630,478 | | |
| | | |
| | | |
|
| a) | Included
in Convertible Notes are loans provided to the Company from two directors and an officer.
The notes each have the following terms: three-year subordinated convertible promissory note
of principal face amounts. Subject to other customary terms, a convertible promissory note
with a principal amount of $600,000 payable to a director, together with accrued interest
of $235,900, was converted into 379,955 shares of the Company’s common stock. The other
remaining convertible promissory notes matured in May 2025, bear interest at an annual rate
of 10% thereafter, which is payable annually in cash or common stock, at the holder’s
discretion. At any time after issuance and prior to or on the maturity date, the notes are
convertible at the option of the holder into shares of common stock at a conversion price
of $3 per share. |
During
2023, the Company issued convertible promissory notes. As an inducement to enter the financing transactions, the Company issued 1,391,667
warrants to the noteholders at an adjusted exercise price of $2.7 per warrant. The Company recorded a debt discount aggregating $5.6
million which was recognized as debt discount and additional paid-in capital in the accompanying balance sheet. The Company recognized
$1,113,996 and $835,496 as amortized debt discount during the year ended December 31, 2025, and 2024, respectively, and it is reflected
as interest expense in the accompanying unaudited consolidated statement of operations.
| b) | In
March 2024, and as amended in June 2025, the Company and the Belami sellers entered into
a letter agreement modifying certain obligations under the Belami stock purchase agreement.
In connection with the letter agreement, the Company issued convertible promissory notes
to each of the sellers (the “Seller Note(s)”) in substitution of an aggregate
of $3,117,909 in cash due to the sellers in monthly principal and interest payments of $300,000
beginning in July 2025 until fully paid in January 2026. The notes are convertible at $3
per share of common stock. |
Additionally,
the convertible promissory notes include a $1 million note payable to GE issued in April 2024. The convertible note is due in April 2027,
does not bear interest and is convertible at a price of $1.07 per share.
| c) | During
2025, the Company consolidated convertible notes aggregating $9.1 million with convertible
notes generating proceeds of $5.2 million. The terms are substantially the same with the
exception of the convertible rate which is $1.20 per share of the Company’s common
stock. |
|
| SCHEDULE OF FUTURE PRINCIPAL PAYMENTS |
As
of December 31, 2025, the expected future principal payments for the Company’s debt are due as follows:
SCHEDULE
OF FUTURE PRINCIPAL PAYMENTS
| | | |
| | |
| Twelve months ended December 31, 2026 | | |
$ | 2,594,529 | |
| Twelve months ended December 31, 2027 | | |
| 1,703,847 | |
| Twelve months ended December 31, 2028 | | |
| 3,994 | |
| Twelve months ended December 31, 2029 | | |
| 4,146 | |
| Twelve months ended December 31, 2030 and thereafter | | |
| 15,029,327 | |
| Total | | |
$ | 19,335,843 | |
|